[New drugs in the treatment of noninfectious uveitis].

Uveitis is considered to cause approximately 10% of blindness in the USA. This underlies the need for new treatments for some noninfectious uveitis, as the success rate of conventional immunosuppressant treatments is low and involve important side effects. Accordingly, it is necessary to research with new drugs having a more selective action mechanism with more potency for controlling long-term ocular inflammation and milder collateral side effects.